EUVIMEDEUVIMED entdecken
Crossref

Interferon-induced senescent CD8 + T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer

Tong Fu iD, Xi Jin iD, Min He iD, Yi-Yu Chen iD, Yun-Song Yang iD, Li Chen, Hu-Yun-Long Zhang iD, Lei Fan iD, Jiong Wu iD, Zhong-Hua Wang, Yi-Wei Chu, Rong-Hua Liu iD und 2 weitere

Science Translational Medicine · 10.09.2025 · 17 (815)

DOI: 10.1126/scitranslmed.adj7808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 10.09.2025. Verfasst von Tong Fu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Precision Cancer Medicine Center, Fudan University Shanghai Cancer Center,…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, CD8-Positive T-Lymphocytes, Immunotherapy, Cellular Senescence. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 69 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancers (TNBCs) lack predictive biomarkers to guide immunotherapy, especially during early-stage disease. To address this issue, we used single-cell RNA sequencing, bulk transcriptomics, and pathology assays on samples from 171 patients with early-stage TNBC receiving chemotherapy with or without immunotherapy. Our investigation identified an enriched subset of interferon (IFN)–induced CD8 + T cells in early TNBC samples, which predict immunotherapy nonresponsiveness. Mechanistically, IFN produced by HLA-DR + monocytes triggered cellular senescence in CD8 + T cells, which was marked by excessive NAD + consumption, reduced cytotoxicity, and immunotherapy nonresponsiveness. Nicotinamide mononucleotide treatment restored the function of IFN-induced senescent CD8 + T cells and enhanced immunotherapy efficacy in patient-derived organoid–T cell coculture and in mouse models. Overall, our study identifies IFN-induced T cell senescence as a driver of immunotherapy nonresponsiveness in early TNBC and provides a strategy to restore CD8 + T cell function for immunotherapeutic benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsCD8-Positive T-LymphocytesImmunotherapyCellular SenescenceInterferonsProgrammed Cell Death 1 ReceptorHumansFemaleAnimalsMiceCell Line, Tumor

Substanzen

InterferonsProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Precision Cancer Medicine Center, Fudan University Shanghai Cancer Center, Shanghai 200032, P. R. China.
  • Department of Immunology, Shanghai Medical School, and Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, P. R. China.
  • Shanghai Fifth People's Hospital, Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai 201100, P. R. China.
  • Shanghai Academy of Natural Sciences (SANS), Fudan University, Shanghai 201203, P. R. China.

ORCID-Profile: Tong Fu, Xi Jin, Min He, Yi-Yu Chen, Yun-Song Yang, Hu-Yun-Long Zhang, Lei Fan, Jiong Wu, Rong-Hua Liu, Yi-Zhou Jiang, Zhi-Ming Shao

Zitieren

APA

Fu, T., Jin, X., He, M., Chen, Y. Y., Yang, Y. S., Chen, L., Zhang, H. Y., Fan, L., Wu, J., Wang, Z. H., Chu, Y. W., Liu, R. H., Jiang, Y. Z., & Shao, Z. M. (2025). Interferon-induced senescent CD8 + T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer. Science Translational Medicine, 17(815). https://doi.org/10.1126/scitranslmed.adj7808

Vancouver

Fu T, Jin X, He M, Chen YY, Yang YS, Chen L, et al. Interferon-induced senescent CD8 + T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer. Science Translational Medicine. 2025;17(815). doi:10.1126/scitranslmed.adj7808

BibTeX
@article{Fu2025,
  author = {Fu, Tong and Jin, Xi and He, Min and Chen, Yi-Yu and Yang, Yun-Song and Chen, Li and Zhang, Hu-Yun-Long and Fan, Lei and Wu, Jiong and Wang, Zhong-Hua and Chu, Yi-Wei and Liu, Rong-Hua and Jiang, Yi-Zhou and Shao, Zhi-Ming},
  title = {Interferon-induced senescent CD8 + T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer},
  journal = {Science Translational Medicine},
  year = {2025},
  volume = {17},
  number = {815},
  doi = {10.1126/scitranslmed.adj7808}
}
Kostenlos starten →